The Effects of Direct-fed Microbial Supplementation, as an Alternative to Antibiotics, on Growth Performance, Intestinal Immune Status, and Epithelial Barrier Gene Expression in Broiler Chickens
- 18 April 2017
- journal article
- research article
- Published by Springer Nature in Probiotics and Antimicrobial Proteins
- Vol. 9 (4) , 397-405
Abstract
The objective of this study was to investigate the effects of Bacillus subtilis-based probiotic supplementation in broiler chicken diets on growth performance, feed efficiency, intestinal cytokine, and tight junction (TJ) protein mRNA expression. Zero-day-old broiler chicks (n = 140) were randomly assigned to one of five dietary treatments: basal diet (CON); basal diet supplemented with either antibiotic bacitracin methylene disalicylate (BMD); or probiotics, namely, B. subtilis strain 1781 (PB1), a combination of B. subtilis strain 1104 + strain 747 (PB2), or B. subtilis strain 1781 + strain 747 (PB3). Body weight and feed intake were measured at 14 days of age, and the feed conversion ratio (FCR) was calculated. At 14 days of age, ileal samples were collected and used for intestinal cytokine, TJ protein, and mucin gene expression analysis using qRT-PCR. The chickens supplemented with antibiotic (BMD) and B. subtilis strain 1781 alone (PB1) had significantly higher body weights compared to controls of the same age. Dietary supplementation with antibiotic (BMD) or probiotics (PB1, PB2, PB3) significantly improved the feed efficiency as evidenced by decreased FCR compared to controls. No differences were observed in the expression of IL1β, IL17F, IFNγ, and MUC2 gene among the different treatment groups. However, elevated expression of IL6 (BMD, PB1, PB2), IL8 (PB2), and TNFSF15 (PB1, PB2, PB3) compared to controls was observed in the ileum. IL2 and IL10 expression was upregulated in chicks in the PB2 and PB3 groups, and IL4 was elevated in the PB1 group. IL13 was elevated in all probiotic-fed groups (PB1, PB2, PB3). Probiotic supplementation was also shown to significantly increase the expression of TJ proteins JAM2, ZO1 (PB2, PB3), and occludin (PB1, PB2). Taken together, B. subtilis supplementation altered intestinal immune activity and influenced gut barrier integrity through increased tight junction gene expression.Keywords
Funding Information
- Agricultural Research Service (ARS CRIS 8042-32000-107-00D)
This publication has 31 references indexed in Scilit:
- Cloning, Annotation and Developmental Expression of the Chicken Intestinal MUC2 GenePLOS ONE, 2013
- Effect of supplementation of Bacillus subtilis LS 1-2 to broiler diets on growth performance, nutrient retention, caecal microbiology and small intestinal morphologyResearch in Veterinary Science, 2012
- Occludin regulates macromolecule flux across the intestinal epithelial tight junction barrierAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2011
- Regulation of Tight Junction Permeability by Intestinal Bacteria and Dietary Components1,2The Journal of Nutrition, 2011
- Morphometric evaluation of “dysbacteriosis” in broilersAvian Pathology, 2011
- Intestinal Goblet Cells and Mucins in Health and Disease: Recent Insights and ProgressCurrent Gastroenterology Reports, 2010
- Probiotics-host communicationGut Microbes, 2010
- Changes in immune-related gene expression and intestinal lymphocyte subpopulations following Eimeria maxima infection of chickensVeterinary Immunology and Immunopathology, 2006
- Differential cytokine mRNA expression in heterophils isolated from Salmonella‐resistant and ‐susceptible chickensImmunology, 2004
- Competitive exclusion by Bacillus subtilis spores of Salmonella enterica serotype Enteritidis and Clostridium perfringens in young chickensVeterinary Microbiology, 2003